Fundraising Fox

InFocus Capital Partners, LLC

Venture capital

Jericho · Seed–Series A · 15 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

InFocus Capital Partners specializes in sourcing, capitalizing, and developing disruptive life sciences opportunities with a specific focus on ophthalmic innovation. The firm combines real-world clinical ophthalmic expertise with venture investment experience, leveraging a partnership structure and deep coverage of the ophthalmology field to identify differentiated opportunities and improve the probability of successful returns.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Jericho, New York, US
Instruments
Equity
Founded
2016
Tracked investments
2

Team · 15 people

from the firm's website & public directories
Aron Shapiro· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member and SVP of Asset Development & Partnering at Ora, Inc.

David L. Katz· Medical Advisor, PL Developments

Advisory board member serving as Medical Advisor at PL Developments.

Donald Fishbein· President, Evolve Therapeutics

Advisory board member and President of Evolve Therapeutics.

Jeffrey Smith· CEO & Chief Investment Officer, Starboard Value LP

Advisory board member and CEO and CIO of Starboard Value LP.

Jodi Luchs· Chief Science Advisor

InFocus Capital Partners Chief Science Advisor and Co-Medical Director of Eyevance Pharmaceuticals.

Matt Chapin· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member serving as SVP of Asset Development & Partnering at Ora, Inc.

Parag A. Majmudar· President & Chief Medical Officer, Chicago Cornea Consultants, Ltd.

Advisory board member and President and Chief Medical Officer of Chicago Cornea Consultants.

What they invest in

from 2 of 2 portfolio companies

Biotech ×2Healthtech ×2Medical Devices ×2

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path
ONL Therapeuticsonltherapeutics.com✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)David Esposito(Executive Officer, Director)Constance Chang(Executive Officer)John K Freshley(Executive Officer, Director)Jeffrey A Jamison(Executive Officer)David N Zacks(Executive Officer, Director)

Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersJohnson & Johnson Innovation – JJDC+3 more

Trefoil Therapeuticstrefoiltherapeutics.comin✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight VenturesSolasta VenturesAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth Ventures+2 more

Frequently asked questions

What stage does InFocus Capital Partners, LLC invest at?
InFocus Capital Partners, LLC invests at the Seed, Series A stages.
What sectors does InFocus Capital Partners, LLC focus on?
InFocus Capital Partners, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is InFocus Capital Partners, LLC located?
InFocus Capital Partners, LLC is headquartered in Jericho, US.

Similar investors

Featured in lists